What Maves charges
Maves advertises $189. That buys the first month. The standing rate is $249/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $189 first month, then $249/month
- Compounded tirzepatide: $249 first month, then $349/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Maves' $249 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. Before you pay, compare Maves' cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Wellorithm dispenses semaglutide and tirzepatide from $247/month, which makes it the fair comparison to run before you commit here.
What Maves dispenses
Maves prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
Maves tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Maves. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against Maves. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Maves also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Maves bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
Our read
Maves is a cheap way to start and an ordinary way to continue. Use the $189 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $249/month before you let it renew twice. Direct Meds is the nearest comparison we review, and worth reading alongside this.